Prevalence and treatment patterns of psoriatic arthritis in the UK

Overview of attention for article published in Rheumatology, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 1 news outlet

policy: 1 policy source

Readers on

mendeley: 177 Mendeley
citeulike: 1 CiteULike

Summary News Policy documents

So far, Altmetric has seen 2 policy documents that reference this research output.

Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 30 Jun 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs : Committee papers

Cited by National Institute for Health and Care Excellence on 20 Jun 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.